CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.48%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.8B
AUM Growth
+$630M
(+4.4%)
Cap. Flow
-$386M
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
926
New
50
Increased
255
Reduced
457
Closed
57
Top Buys
| 1 |
Mercado Libre
MELI
|
$41.1M |
| 2 |
Darling Ingredients
DAR
|
$37M |
| 3 |
Johnson & Johnson
JNJ
|
$34.5M |
| 4 |
Veru
VERU
|
$34M |
| 5 |
MetLife
MET
|
$31.5M |
Top Sells
| 1 |
PepsiCo
PEP
|
$46.7M |
| 2 |
Nike
NKE
|
$42.5M |
| 3 |
Illinois Tool Works
ITW
|
$37M |
| 4 |
Gilead Sciences
GILD
|
$32.3M |
| 5 |
Merck
MRK
|
$30.3M |
Sector Composition
| 1 | Healthcare | 33.31% |
| 2 | Technology | 22.85% |
| 3 | Financials | 10.04% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
ConocoPhillips
COP
$116B
| $12.6M | 0.08% |
106,376
-144,933
| -58% | -$17.1M |
|
227
Guardant Health
GH
$7.5B
| $12.5M | 0.08% |
459,644
+270,594
| +143% | +$7.36M |
|
228
Trex
TREX
$6.93B
| $12.4M | 0.08% |
293,262
| – | – |
|
229
Datadog
DDOG
$47.5B
| $12.4M | 0.08% |
168,835
-613
| -0.4% | -$45.1K |
|
230
Sarepta Therapeutics
SRPT
$1.96B
| $12.3M | 0.08% |
+95,144
| New | +$12.3M |
|
231
Fortinet
FTNT
$60.4B
| $12.3M | 0.08% |
250,925
-139,339
| -36% | -$6.81M |
|
232
Ormat Technologies
ORA
$5.51B
| $12.3M | 0.08% |
141,818
-35,295
| -20% | -$3.05M |
|
233
Comerica
CMA
$8.85B
| $12.2M | 0.08% |
181,838
-65,709
| -27% | -$4.39M |
|
234
Crown Holdings
CCK
$11B
| $11.9M | 0.08% |
145,238
+7,206
| +5% | +$592K |
|
235
Annaly Capital Management
NLY
$14.2B
| $11.9M | 0.08% |
565,706
+21,335
| +4% | +$450K |
|
236
Aflac
AFL
$57.2B
| $11.9M | 0.08% |
164,828
-17,357
| -10% | -$1.25M |
|
237
Dover
DOV
$24.4B
| $11.8M | 0.08% |
87,248
+53,450
| +158% | +$7.24M |
|
238
eBay
EBAY
$42.3B
| $11.8M | 0.08% |
283,725
+27,164
| +11% | +$1.13M |
|
239
TransUnion
TRU
$17.5B
| $11.8M | 0.08% |
207,124
+23,353
| +13% | +$1.33M |
|
240
Cerence
CRNC
$399M
| $11.6M | 0.08% |
626,578
-539
| -0.1% | -$9.99K |
|
241
Labcorp
LH
$23.2B
| $11.5M | 0.08% |
57,043
-9,783
| -15% | -$1.98M |
|
242
Cogent Biosciences
COGT
$1.82B
| $11.5M | 0.08% |
997,141
-154,361
| -13% | -$1.78M |
|
243
Akero Therapeutics
AKRO
$3.58B
| $11.5M | 0.08% |
+210,000
| New | +$11.5M |
|
244
Keurig Dr Pepper
KDP
$38.9B
| $11.5M | 0.08% |
321,591
+206,759
| +180% | +$7.37M |
|
245
KLA
KLAC
$119B
| $11.3M | 0.08% |
30,034
-17,779
| -37% | -$6.7M |
|
246
Target
TGT
$42.3B
| $11.3M | 0.08% |
75,971
-2,153
| -3% | -$321K |
|
|
BPMC
247
DELISTED
Blueprint Medicines
BPMC
| $11.3M | 0.08% |
258,311
| – | – |
|
248
LKQ Corp
LKQ
$8.33B
| $11.3M | 0.08% |
210,849
+54,480
| +35% | +$2.91M |
|
|
ESGR
249
DELISTED
Enstar Group
ESGR
| $11.1M | 0.08% |
48,203
-13,151
| -21% | -$3.04M |
|
250
Pacira BioSciences
PCRX
$1.19B
| $11.1M | 0.07% |
224,901
+45,000
| +25% | +$2.21M |
|